Login

Diamyd Medical | interview with CEO Ulf Hannelius 00:00:00

Share On Facebook Share On Twitter

Diamyd Medical | interview with CEO Ulf Hannelius

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Roberto Funari, on Leadership, Career Growth, and Building High-Performing Teams | Roberto Funari, CEO , Alpargatas SA.
00:10:00
Michael Vodicka analyzes Diodes, Inc. (DIOD) for its semiconductor prospects and Central Garden & Pet Company for its position in the consumer goods market.|Keh-Shew Lu. Chairman and Chief Executive Officer of Diodes, Inc
00:00:00
Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine
00:10:00
Jonathan Satchell, CEO, and Neil Elton, Group FD of Learning Technologies Group (LTG), share insights on their company's progress.
00:10:00
Zalaris - executive interview | Hans-Petter Mellerud, CEO, Zalaris ASAZAL:OSL
00:10:00
Kiliaro Group AB Q2 Report: Insights from CEO Elie Komo | Elie Komo, CEO, Kiliaro Group AB.
00:10:00
Paying Yourself First: What It Means and How to Do It | Ian draws , Founder , Open World Financial Life Planning.
00:00:00
Admedus Ltd 'in good shape' with minimal disruption to supply chain as it advances SAVR trial - Wayne Paterson, CEO, Admedus Ltd
00:10:00
Real-Time Geospatial Intelligence: A Shift Unveiled by Brian O'Toole | Brian O’Toole - CEO of BlackSky
00:10:00
Tribeca Resources Focuses on Major IOCG Deposits in Northern Chile
00:10:00
advice for open source founders|Astasia Myers, Founding Partner,Quiet Capital
00:10:00
Mastering Market Challenges and Expansion: A Conversation with South Africa's Real Estate Chief | Izak Petersen , CEO ,Dipula Income Fund Ltd.

© 2017 - Neuhu+